Terms: = Leukemia AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Diagnosis
7 results:
1. Secondhand smoke: A new and modifiable prognostic factor in childhood acute lymphoblastic leukemias.
Cárceles-Álvarez A; Ortega-García JA; López-Hernández FA; Fuster-Soler JL; Ramis R; Kloosterman N; Castillo L; Sánchez-Solís M; Claudio L; Ferris-Tortajada J
Environ Res; 2019 Nov; 178():108689. PubMed ID: 31479979
[TBL] [Abstract] [Full Text] [Related]
2. Solid organ transplantation after treatment for childhood cancer: a retrospective cohort analysis from the Childhood Cancer Survivor Study.
Dietz AC; Seidel K; Leisenring WM; Mulrooney DA; Tersak JM; Glick RD; Burnweit CA; Green DM; Diller LR; Smith SA; Howell RM; Stovall M; Armstrong GT; Oeffinger KC; Robison LL; Termuhlen AM
Lancet Oncol; 2019 Oct; 20(10):1420-1431. PubMed ID: 31471158
[TBL] [Abstract] [Full Text] [Related]
3. Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to diagnosis data, 2006-2015.
Herbert A; Abel GA; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G
Br J Gen Pract; 2019 Oct; 69(687):e724-e730. PubMed ID: 31455644
[TBL] [Abstract] [Full Text] [Related]
4. Maternal fetal loss history and increased acute leukemia subtype risk in subsequent offspring: a systematic review and meta-analysis.
Karalexi MA; Dessypris N; Skalkidou A; Biniaris-Georgallis S-; Kalogirou ΕΙ; Thomopoulos TP; Herlenius E; Spector LG; Loutradis D; Chrousos GP; Petridou ET
Cancer Causes Control; 2017 Jun; 28(6):599-624. PubMed ID: 28401353
[TBL] [Abstract] [Full Text] [Related]
5. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Gunnarsson N; Stenke L; Höglund M; Sandin F; Björkholm M; Dreimane A; Lambe M; Markevärn B; Olsson-Strömberg U; Richter J; Wadenvik H; Wallvik J; Själander A
Br J Haematol; 2015 Jun; 169(5):683-8. PubMed ID: 25817799
[TBL] [Abstract] [Full Text] [Related]
6. [Long-term follow up of chronic myelogenous leukemia patients treated with natural interferon alpha--multi-institutional cooperative study].
Urabe A; Asano S; Mizoguchi H; Aoki N; Takaku F
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1541-6. PubMed ID: 11015999
[TBL] [Abstract] [Full Text] [Related]
7. Hepatitis B and C viruses, human T-cell lymphotropic virus types I and II, and leukemias: a case-control study. The Italian leukemia Study Group.
Gentile G; Mele A; Monarco B; Vitale A; Pulsoni A; Visani G; Castelli G; Rapicetta M; Verani P; Martino P; Mandelli F
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):227-30. PubMed ID: 8833624
[TBL] [Abstract] [Full Text] [Related]